期刊文献+

HSP70在放线菌素D所致肺腺癌细胞增殖抑制和凋亡中的作用 被引量:2

Roles of HSP 70 in Actinomycin D-Induced Inhibition of Proliferation and Apoptosis in Lung Adenocarcinoma Cell
下载PDF
导出
摘要 为探讨热休克蛋白70(heatshockprotein70,HSP70)在肺腺癌中的表达及其作用,首先采用免疫印迹检测经临床支纤镜确诊并行手术切除的肺腺癌组织标本中HSP70的表达,结果显示在癌旁正常组织中HSP70的表达量显著低于其在癌组织中的表达量.其次,采用HSP70反义寡核苷酸阻断A549细胞中HSP70表达后,经MTT和Hoechst33258检测发现,HSP70下调能显著促进放线菌素D(actinomycinD,ActD)所致的A549细胞增殖抑制及凋亡,反义寡核苷酸处理组与正义或随机寡核苷酸处理组比较P值均小于0.05.进一步构建HSP70真核重组质粒并瞬时转染A549细胞后,能显著增加A549细胞中HSP70表达,同时采用MTT和流式细胞术及基因组DNA琼脂糖凝胶电泳检测发现,HSP70过表达能显著抵消ActD所致细胞增殖抑制及凋亡,转染HSP70重组质粒组与转染空载体组相比P值小于0.05.上述结果提示,HSP70在肺腺癌组织中高表达,高表达的HSP70在降低肺腺癌细胞对ActD的敏感性及促进癌细胞增殖与抑制凋亡等方面发挥了重要作用. It had been proved by many evidences that several heat shock proteins (HSPs) expression is up-regulated in tissue-derived primary lung cancer, and HSPs may play important roles in development, in resistant to drugs and in prognosis of lung cancer. However, there have not still systemic research on which HSPs, especially HSP70 can be or not thought as a new biological target in the therapy to lung cancer. In order to address the expression and roles of heat shock protein 70 (HSP70) in lung adenocarcinoma, immunoblotting was performed to detect the expression of HSP70 in tissue specimens from lung adenocarcinoma which were diagnosed unambiguously by branch fibromicroscopy and were excised. It showed that in the normal lung tissues, the expression of HSP70 was less then that in cancer tissues. After down-regulation of HSP70 protein by HSP70 anti-sense oligonucleotides in A549 cell line, MTT assay showed that the proliferation ofA549 cells was inhibited remarkably after the treatment with HSP70 antisense oligonucleotides and Act D. There had significant differential in HSP70 antisense treatment group followed by Act D treatment and Act D treatment group. Results of Hoechst33258 staining revealed that HSP70 antisense oligonucleotides could promote Act D-mediated apoptosis in A549 cells with a higher percentage of apoptotic cells (26.91±3.73)% than that of Act D-treated group (16.83±3.41)% (P 〈 0.01). Furthermore, the expression of HSP70 protein was increased remarkably by transfection with a full length HSP70 recombinant plasmid into A549 cells. MTT assay revealed that HSP70 over-expression could block significantly the inhibition of proliferation induced by Act D, there had statistic significance between HSP70 over-expression group and only Act D-treated group (P 〈 0.01). Furthermore, over-expression of HSP70 could significantly inhibit Act D-mediated apoptosis in A549 cells with a lower percentage of apoptotic cells (4.25±1.48)% in HSP70 transfection group, (12.89±2.03)% in vector transfection group and (14.37±2.56)% in Act D treatment group and disappearance of DNA laddering. These results suggests that increased levels of HSP70 in lung adenocarcinoma tissues decrease the sensitivity of lung adenocarcinoma to Act D, promote proliferation and suppress apoptosis of lung adenocarcinoma cells.
出处 《生物化学与生物物理进展》 SCIE CAS CSCD 北大核心 2007年第1期42-49,共8页 Progress In Biochemistry and Biophysics
基金 湖南省科技厅计划资助项目(05FJ3062).~~
关键词 热休克蛋白70 肺腺癌 增殖 凋亡 A549细胞 放线菌素D heat shock protein 70 (HSP70), lung adenocarcinoma, proliferation, apoptosis, actinomycin D(Act D), A549 cell line
  • 相关文献

参考文献12

  • 1陆舜.非小细胞肺癌综合治疗新进展[J].中国肺癌杂志,2005,8(1):74-76. 被引量:21
  • 2Liberman M, Liberman D, Sampalis J S, et al. Delays to surgery in non-small-cell lung cancer. Can J Surg, 2006, 49 (1): 31 -36.
  • 3Benjamin I J, McMillan D R. Stress (heat shock) proteins molecular chaperones in cardiovascular biology and disease. Circ Res,1998,83:117-132.
  • 4Xiao X Z, Benjamin I J. Stress-response proteins in cardiovascular disease. Am J Hum Genet, 1999, 64:685-690.
  • 5Macario A J. Heat-shock proteins and molecular chaperones:implications for pathogenesis, diagnostics, and therapeutics, Int J Clin Lab Res, 1995, 25 (2): 59-70.
  • 6战润庆,董驹,张树波,马立人,李新,王国臣,郑毛根,陈志全.肺腺癌GLC-82细胞HSP70表达与放化疗敏感性[J].中国肿瘤,2005,14(2):126-129. 被引量:3
  • 7Volm M, Mattem J, Stammler G. Up-regulation of heat shock protein 70 in adenocarcinomas of the lung in smokers. Anticancer Res, 1995, 15 (6B): 2607-2609.
  • 8Ray S, Lu Y, Kaufmann S H, et ol. Genomic mechanisms of p210BCR-ABL signaling: induction of heat shock protein 70 through the GATA response element confers resistance topaclitaxel-induced apoptosis. J Biol Chem, 2004, 279(34):35604-35615.
  • 9Kregel K C. Molecular biology of thermoregulation invited review:heat shock proteins: modifying factors in physiological stress responses and acquired thermotolerance. J Appl Physio, 2002, 192:2177-2186.
  • 10Jolly C, Morimoto R I. Role of the heat shock response and molecular chaperones in oncogenesis and cell death. J Nat1 CancerRes Inst, 2000, 92: 1564- 1572.

二级参考文献19

  • 1Maitykao GD, Muschel R J, McKenna WG. Potential molecular targets for manipulating the radiation response [J]. Int J Radiat Oncol Biolphys, 1997,37(3): 639-653.
  • 2Mehlen P, Schulze-Osthoff K, Arrigo AP. Small stress proteins as novel regulators of apoptosis. Heat shock protein 27 blocks Fas/APO-1 and staurosporine-induced cell death[J]. J Biol Chem, 1996,271 (28): 16510-16514.
  • 3Messmer UK, Burne B. Nitric oxide-induced apoptosis:p53-dependent and p53-independent signalling pathways [J]. Biol Chem J,1996,319(Pt 1):299-305.
  • 4He L, Fox MH. Variation of heat shock protein 70 through the cell cycle in HL-60 cells and its relationship to apoptosis[J]. Exp Cell Res, 1997,232(1):64-71.
  • 5Sliutz G, Karlser J, Temfer C, et al. Drug resistance against gemcutabine and topotecan mediated by constitutive HSP70 over-expression in vitro: implication of quercetin as sensitiser in chemotherapy [J]. Br J Cancer,1996,74(2): 172-177.
  • 6Kim TY, Yang SH, Lee SH, et al. A phase Ⅲ randomized trial of combined chemoradiotherapy versus radiotherapy alone in locally advanced non-small-cell lung cancer. Am J Clin Oncol,2002,25(3): 238-243.
  • 7Morris DE, Rosenman JG, Halle JS, et al.Induction chemotherapy followed by doseescalated thoracic 3 dimensional conformal radiation therapy to 90 Gy with concurrent chemotherapy in stage Ⅲ A/B non-small cell lung cancer: a phase Ⅰ radiation dose escalation trial. Int J Radiat Oncol Biol Phys,2003,57(2 Suppl): S138-S139.
  • 8Chemotherapy in non small cell lung cancer:a meta-analysis using updated data on indi vidual patients from 52 randomised clinical trials. Non-small Cell Lung Cancer Collaborative Group. BMJ,1995,311(7010) : 899-909.
  • 9Le Chevalier T, for the IALT Investigators.Results of the Randomized International Ad juvant Lung Cancer Trial (IALT): cisplatinbased chemotherapy (CT) vs no CT in 1867patients (pts) with resected non small cell lung cancer (NSCLC). Proc Am Soc Clin Oncol,2003,23(abstr. 6).
  • 10PORT Meta-analysis Trialists Group. Postoperative radiotherapy for non-small cell lung cancer (Cochrane Review) [J/CD].The Cochrane Library, Issue 1,2001. Oxford: Update Software.

共引文献22

同被引文献27

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部